Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Event

LivaNova to Present at the Barclays Global Healthcare Conference


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced Damien McDonald, Chief Executive Officer, will present in a fireside chat at the Barclays Global Healthcare Conference in Miami, Florida. The presentation will take place at 9 a.m. Eastern Time on Thursday, March 16.

The discussion will be available to all interested parties who register to attend the webcast, which is accessible via www.livanova.com/events. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the webcast. A replay will be available on the LivaNova website within 24 hours after the live presentation for 90 days after the event.

About LivaNova

LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through innovative medical technologies, delivering life-changing improvements for both the Head and Heart. Headquartered in London, LivaNova employs approximately 2,900 employees and has a presence in more than 100 countries for the benefit of patients, healthcare professionals and healthcare systems worldwide. For more information, please visit www.livanova.com.

Safe Harbor Statement

This news release contains "forward-looking statements" concerning the Company's goals, beliefs, expectations, strategies, objectives, plans and underlying assumptions and other statements that are not necessarily based on historical facts. These statements include, but are not limited to, statements regarding participation in upcoming events. Actual events may differ materially from those indicated in our forward-looking statements as a result of various factors, including those factors set forth in Item 1A of the Company's most recent Annual Report on Form 10-K, as supplemented by any risk factors contained in Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. LivaNova undertakes no obligation to update the information contained in this press release to reflect subsequently occurring events or circumstances.


These press releases may also interest you

at 10:11
The Prime Minister, Justin Trudeau, today announced the reappointment of Dr. Mona Nemer as Canada's Chief Science Advisor for a term of three years, effective September 25, 2024. A distinguished medical researcher, Dr. Nemer has served as Canada's...

at 10:10
The "TechVision50: Top 50 Advanced and Emerging Technologies" report has been added to ResearchAndMarkets.com's offering. TechVision50 is a guide of the 50 greatest opportunities in Advanced Technologies and Materials at the mid-point of 2024. This...

at 10:10
The "Viral Vector Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Viral Vector Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the viral...

at 10:05
The "The Worldwide Market for Clinical Laboratory Services, 9th Edition" report has been added to ResearchAndMarkets.com's offering. Stay ahead with insights into demographic trends, disease trends, new developments, company performance, mergers...

at 10:00
The "Drug Delivery Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Drug Delivery Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the drug...

at 09:15
Health providers from the Registered Nurses' Association of Ontario's (RNAO) Best Practice Spotlight Organizations® (BPSO®) will meet in Thunder Bay for an inaugural knowledge-sharing event. Hosted by RNAO and developed with BPSOs, the...



News published on and distributed by: